Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

 

TABLE OF CONTENTS

 

 

 

Page

 

 

 

1.

Registration Rights

2

 

1.1

Definitions

2

 

1.2

Request for Registration

3

 

1.3

Company Registration

4

 

1.4

Form S-3 Registration

5

 

1.5

Obligations of the Company

6

 

1.6

Information from Holder

7

 

1.7

Expenses of Registration

7

 

1.8

Delay of Registration

8

 

1.9

Indemnification

8

 

1.10

Reports Under Securities Exchange Act of 1934

10

 

1.11

Assignment of Registration Rights

10

 

1.12

“Market Stand-Off” Agreement

11

 

1.13

Limitations on Subsequent Registration Rights

11

 

1.14

Termination of Registration Rights

12

 

 

 

 

2.

Covenants of the Company

12

 

2.1

Delivery of Financial Statements

12

 

2.2

Inspection

13

 

2.3

Termination of Information and Inspection Covenants

13

 

2.4

Right of First Offer

13

 

2.5

Board of Directors

16

 

2.6

Required Notices

18

 

2.7

Key Person Insurance

19

 

2.8

Approval of Certain Issuances

19

 

2.9

Real Property Holding Company

19

 

2.10

Tax Disclosure

20

 

2.11

Confidentiality

20

 

2.12

Termination of Certain Covenants

20

 

 

 

 

3.

Miscellaneous

21

 

3.1

Successors and Assigns

21

 

3.2

Governing Law

21

 

3.3

Counterparts

21

 

3.4

Titles and Subtitles

21

 

3.5

Notices

21

 

3.6

Expenses

21

 

3.7

Entire Agreement; Amendments and Waivers

22

 

3.8

Severability

22

 

3.9

Aggregation of Stock

22

 

3.10

Additional Investors

22

 

3.11

Termination of Prior Agreement

22

 

i